When pigmentation goes wrong – Treatments

Skin pigmentation disorders arise from an overproduction or uneven distribution of melanin, the pigment responsible for skin colour. Different triggers such as genetics, sun exposure, and specific medications can exacerbate these conditions.

Understanding the mechanisms behind common pigmentation issues can inform effective prevention and treatment strategies.

Pigmentary disorders can indeed be broadly categorised into two main types based on the presence or absence of pigment: hyperpigmentation and hypopigmentation.

Hyperpigmentation refers to conditions where there is an excess of melanin, leading to darkened areas of skin. This overproduction of pigment can be localised to specific areas or more widespread.

Hypopigmentation occurs when there is a reduction in melanin, leading to lighter patches of skin. This can result from a decrease in melanocyte activity or a reduction in the number of melanocytes.

Cosmelan before and after Melasma

Cosmelan before and after Melasma

Hyperpigmentation disorders and their treatments.

Each of the hyperpigmentation disorders discussed below have distinct triggers, but they all share a common factor: an overproduction or uneven distribution of melanin. Understanding the underlying causes is crucial for both prevention and effective management, making it possible to tailor treatments to specific conditions and skin types.

Effective treatment often involves a combination of sun protection, professional pigmentation reducing skin care, and aesthetic treatments, such as; laser therapy, microneedling or chemical peels.

Diagnosing the type of pigmentation is also an essential step in determining the most appropriate treatment plan. A crucial tool in this diagnostic process is the skin scanner, which emits ultraviolet (UV) light, allowing for a detailed examination of the skin. This tool can help differentiate between different types of pigmentation based on their depth and characteristics.

UV Detailed Skin Examination

UV Detailed Skin Examination

NEXT – Part Three. Melasma